Spots Global Cancer Trial Database for skin cancer
Every month we try and update this database with for skin cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Helping Children be Safe Outdoors With Sun Protection | NCT02177006 | Sun Sensitivity Sun Protection Skin Cancer | Sun Protection ... | 18 Years - | Northwestern University | |
| Phase I of Histone Deacetylase (HDAC) Inhibitor Panobinostat With Ipilimumab With Unresectable III/IV Melanoma | NCT02032810 | Melanoma Skin Cancer | Panobinostat Ipilimumab | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Fluorescein for Lymphatic Mapping and Sentinel Lymph Node (SLN) Biopsy in Patients With Stage I and II Malignant Melanoma | NCT00847522 | Cancer | Fluorescein | 18 Years - | University of Utah | |
| Carboplatin, Paclitaxel, and Temozolomide for Patients With Metastatic Melanoma | NCT01009515 | Melanoma | Paclitaxel, car... | 18 Years - | New Mexico Cancer Care Alliance | |
| Eflornithine and/or Diclofenac in Treating Patients With Sun-Damaged Skin | NCT00601640 | Other Benign Ne... | Diclofenac Na g... Eflornithine HC... | 40 Years - | University of Arizona | |
| Pilot Investigation of Behavioral Alternatives to Indoor Tanning | NCT02192918 | Skin Cancer | Airbrush Airbrush Plus Delayed Airbrus... | 16 Years - 65 Years | University of Massachusetts, Worcester | |
| Development and Validation of a New Digital Dermatoscope in the United States | NCT04047316 | Skin Cancer | Digital dermosc... | - | Barco NV | |
| Fluorescein for Lymphatic Mapping and Sentinel Lymph Node (SLN) Biopsy in Patients With Stage I and II Malignant Melanoma | NCT00847522 | Cancer | Fluorescein | 18 Years - | University of Utah | |
| Evaluation of Sun Protection Education for Kidney Transplant Recipients | NCT01844713 | Unspecified Com... Disorder Relate... | Workbook | 18 Years - 85 Years | Northwestern University | |
| QI: Patient Satisfaction With Facial Appearance, Scar Outcome and Quality of Life After Skin Cancer Surgery | NCT03503240 | Skin Cancer | 21 Years - | Memorial Sloan Kettering Cancer Center | ||
| Study of Afatinib in Advanced Cutaneous Squamous Cell Carcinoma | NCT05070403 | Squamous Cell C... | Afatinib 40 MG | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Study of TVEC in Patients With Cutaneous Squamous Cell Cancer | NCT03714828 | Squamous Cell C... Skin Cancer Keratoacanthoma Cutaneous Tumor Skin Cancer, Sq... Lesion Skin | Injection of TV... Injection of TV... Injection of TV... Injection of TV... | 18 Years - | University of Arizona | |
| Melanoma Vaccine With Peptides and Leuprolide | NCT00254397 | Melanoma | Leuprolide GP100: 209-217(... MAGE-3 Peptide | 18 Years - | M.D. Anderson Cancer Center | |
| Studying a Tumor Marker for Testicular Cancer, Skin Cancer, Small Intestine Cancer, and Pancreatic Cancer | NCT00899132 | Non-melanomatou... Pancreatic Canc... Small Intestine... Testicular Germ... | in situ hybridi... protein express... immunologic tec... | - | Case Comprehensive Cancer Center | |
| Clinical Trial of HuMax-CD4, a New Drug to Treat Early Stage T-Cell Lymphoma in the Skin. | NCT00071071 | Cutaneous T-Cel... | HuMax-CD4 HuMax-CD4 | 18 Years - | Genmab | |
| Topical Fluorescent Nanoparticles Conjugated Somatostatin Analog for Suppression and Bioimaging Breast Cancer | NCT04138342 | Breast Cancer Skin Cancer Skin Diseases | Quantum dots co... Topical approve... | 25 Years - 60 Years | Al-Azhar University | |
| Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors | NCT04354064 | Healthy Volunte... Prostate Cancer Head and Neck C... Esophageal Canc... Genitourinary C... Sarcoma Breast Cancer Colon Cancer Gastrointestina... Solid Tumor Can... Lung Cancer Skin Cancer Melanoma | 18 Years - | Washington University School of Medicine | ||
| Biomarker Correlates of Hypoxia in Metastatic Melanoma | NCT02061007 | Melanoma Skin Cancer | Pimonidazole hy... Optional 18F-FM... Surgical Resect... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| CNS and Extracranial Tumor Tissues, CSF, and Blood From Patients With Melanoma Brain Metastases | NCT02058953 | Melanoma Brain Metastase... | Craniotomy sche... Collection for ... | 18 Years - | University of Pittsburgh | |
| Topical Sirolimus in Chemoprevention of Facial Squamous Cell Carcinomas in Solid Organ Transplant Recipients (SiroSkin) | NCT05860881 | Solid Organ Tra... Skin Cancer | Sirolimus Topic... Placebo | 18 Years - | Melanoma and Skin Cancer Trials Limited | |
| Chemotherapy Followed by gp100 Lymphocytes and Aldesleukin to Treat Melanoma | NCT00665470 | Skin Cancer Metastatic Mela... | Aldesleukin | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas. | NCT06022029 | Triple Negative... Diffuse Large B... Follicular Lymp... Lymphoma, Non-H... Mantle Cell Lym... Bladder Cancer Uveal Melanoma,... Cervix Cancer Carcinoma in Si... Head and Neck S... Skin Cancer Metastatic Canc... Tumor, Solid Tumor Recurrenc... | ONM-501 Cemiplimab | 18 Years - | OncoNano Medicine, Inc. | |
| Skin Cancer Diagnostics Using Photoacoustic Imaging | NCT06379581 | Skin Cancer | - | Region Skane | ||
| Reflectance Confocal Microscopy to Diagnose MM & LM | NCT03508297 | Melanoma (Skin) Lentigo Maligna | In-vivo imaging | 18 Years - | Skin Care Network Ltd. | |
| A Clinical Study to Assess the Efficacy and Safety of Alpha DaRT224 for the Treatment of Patients With Recurrent Cutaneous Squamous Cell Carcinoma | NCT05323253 | Recurrent Squam... | DaRT seeds | 18 Years - | Alpha Tau Medical LTD. | |
| The Organ Transplant Recipient HPV and Skin Cancer Study | NCT05284877 | Solid Organ Tra... Skin Cancer Skin Dysplasia HPV Infection Cervical Intrae... Cervical Cancer HPV-Related Mal... | No intervention | 18 Years - | Bispebjerg Hospital | |
| Topical Ascorbic Acid for Treatment of Squamous Cell Skin Cancer | NCT05932511 | Squamous Cell C... Squamous Cell C... Skin Cancer Non-melanoma Sk... | 30% ascorbic ac... | 18 Years - 85 Years | Center for Biomedical Research, Inc. | |
| Basal Cell Carcinoma Recurrence After Mohs Surgery | NCT00882791 | Basal Cell Carc... | 18 Years - | Northwestern University | ||
| Modified Tumor Infiltrating Lymphocytes for Metastatic Melanoma | NCT01369875 | Metastatic Mela... Skin Cancer | Cyclophosphamid... Fludarabine Aldesleukin Tumor Infiltrat... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| The Impact of Total Body Skin Examination on Skin Cancer Detection | NCT00765193 | Melanoma Basal Cell Carc... Squamous Cell C... Merkel Cell Car... Skin Cancer | Inspection of c... | 18 Years - 95 Years | Medical University of Graz | |
| Cabozantinib in Recurrent/Metastatic Merkel Cell Carcinoma | NCT02036476 | Merkel Cell Car... Skin Cancer | Cabozantinib | 18 Years - | Dana-Farber Cancer Institute | |
| AI Augmented Training for Skin Specialists | NCT04758988 | Melanoma Skin Cancer | DermLoop Learn | - | Herlev Hospital | |
| Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia | NCT04534127 | Skin Cancer Mucosal Neoplas... Soft Tissue Neo... | Radiation: Diff... | 18 Years - | Alpha Tau Medical LTD. | |
| Exercise and Diet Interventions During Immunotherapy in Melanoma Patients | NCT06298734 | Melanoma (Skin) Skin Cancer Advanced Melano... | Exercise Progra... Diet Program | 18 Years - | Dana-Farber Cancer Institute | |
| Computer-Based Continuing Education for Doctors in Examination and Counseling of Patients on Skin Cancer or Weight Control | NCT00295906 | Melanoma (Skin) Non-melanomatou... | educational int... internet-based ... | 18 Years - | National Cancer Institute (NCI) | |
| Phase 1 Study of CK-301 (Cosibelimab) as a Single Agent in Subjects With Advanced Cancers | NCT03212404 | Lung Neoplasms Carcinoma, Non-... Carcinoma, Smal... Malignant Mesot... Head and Neck C... Melanoma Merkel Cell Car... Renal Cell Carc... Urothelial Carc... Classical Hodgk... Cutaneous Squam... Non Hodgkin Lym... Endometrial Can... | CK-301 (cosibel... | 18 Years - | Checkpoint Therapeutics, Inc. | |
| Evaluating Safety and Biomarkers Using DK210 (EGFR) for Locally Advanced or Metastatic EGFR+ Tumors | NCT05704985 | Cancer Solid Tumor Colorectal Canc... Pancreas Cancer Non Small Cell ... Head and Neck C... Gynecologic Can... Skin Cancer Kidney Cancer | DK210 (EGFR) Radiation thera... Immune checkpoi... Chemotherapy | 18 Years - | DEKA Biosciences | |
| ZD1839 (Iressa) for Recurrent or Metastatic Squamous Cell Carcinoma of the Skin | NCT00054691 | Skin Cancer | Iressa | 18 Years - | M.D. Anderson Cancer Center | |
| Study of NS-9 in Patients With Liver Metastases | NCT00094003 | Liver Neoplasms Neoplasm Metast... Local Neoplasm ... | NS-9 [Poly I: P... | 18 Years - | NS Pharma, Inc. | |
| Feasibility of Activity Monitoring in Patients With Cancer: Physical Activity Monitoring in Cancer Patients (PAMCaP) | NCT02583815 | Gastrointestina... Breast Cancer Gynecologic Can... Genitourinary C... Leukemia Lung Cancer Skin Cancer Endocrine Cance... Male Genital Ca... | 18 Years - | University of Texas Southwestern Medical Center | ||
| Use of Shade in U.S. and Australian City Parks | NCT02971709 | Skin Cancer | Shade Sail | 18 Years - | Klein Buendel, Inc. | |
| Spectrally Guided Mohs Surgery | NCT03145506 | Skin Cancer | Multimodal Spec... | 18 Years - 99 Years | Seton Healthcare Family | |
| A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas. | NCT06022029 | Triple Negative... Diffuse Large B... Follicular Lymp... Lymphoma, Non-H... Mantle Cell Lym... Bladder Cancer Uveal Melanoma,... Cervix Cancer Carcinoma in Si... Head and Neck S... Skin Cancer Metastatic Canc... Tumor, Solid Tumor Recurrenc... | ONM-501 Cemiplimab | 18 Years - | OncoNano Medicine, Inc. | |
| A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer | NCT05361174 | Unresectable Me... Metastatic Mela... Stage III Non-s... Stage IV Non-sm... | IOV-4001 | 18 Years - | Iovance Biotherapeutics, Inc. | |
| A Safety and Efficacy Study for Combinational Treatment of DaRT and Check Point Inhibitor for Recurrent Unresectable or mHNSCC | NCT05047094 | Head and Neck S... Skin Cancer Metastatic Head... | Diffusing Alpha... Pembrolizumab | 18 Years - | Alpha Tau Medical LTD. | |
| TLR4 Polymorphisms and Risk of Skin Cancer | NCT03122366 | Skin Cancer | Detection of si... | 50 Years - 99 Years | University of Alabama at Birmingham | |
| Natural History Study of Moles and Suspicious Melanoma | NCT00288938 | Melanocytic Nev... Acquired Melano... Primary Cutaneo... | 5 Years - | National Institutes of Health Clinical Center (CC) | ||
| Body Image Functioning Among Surgically Treated Patients With Head and Neck Cancer | NCT00824174 | Head and Neck C... Skin Cancer | Questionnaire | 18 Years - | M.D. Anderson Cancer Center | |
| Retreatment With Intratumoral Diffusing Alpha Radiation Emitters | NCT04540588 | Skin Cancer Mucosal Neoplas... Soft Tissue Neo... | Radiation: Diff... | 18 Years - | Alpha Tau Medical LTD. | |
| Examination of Clinical and Laboratory Abnormalities in Patients With Defective DNA Repair: Xeroderma Pigmentosum, Cockayne Syndrome, or Trichothiodystrophy | NCT00001813 | Cockayne Syndro... Skin Neoplasms Xeroderma Pigme... Trichothiodystr... Genodermatosis | 6 Weeks - | National Institutes of Health Clinical Center (CC) | ||
| A Study of Tilsotolimod in Combo With Ipilimumab vs Ipilimumab Alone in Subjects With Anti-PD-1 Refractory Melanoma | NCT03445533 | Metastatic Mela... | Ipilimumab Tilsotolimod wi... | 18 Years - | Idera Pharmaceuticals, Inc. | |
| Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene | NCT03602079 | HER2-positive B... HER2 Gene Mutat... HER-2 Gene Ampl... HER2 Positive G... Salivary Gland ... Salivary Gland ... Salivary Gland ... Salivary Gland ... Lung Cancer Colo-rectal Can... Rare Diseases Solid Tumor Recurrent Gastr... Recurrent Colon... Recurrent Breas... Head and Neck C... Head and Neck C... Bladder Cancer Cervical Cancer Liver Cancer Bile Duct Cance... Urologic Cancer Pancreatic Canc... Prostate Cancer Recurrent Prost... Rectal Cancer Recurrent Ovari... Recurrent Renal... Rectal Cancer S... Rectal Cancer S... Rectal Cancer S... Skin Cancer Mouth Cancer Lip Cancer Stag... Tongue Cancer Breast Neoplasm... Larynx Cancer Tonsil Cancer Palate Cancer Mucoepidermoid ... Primary Periton... Mucinous Adenoc... Mucinous Breast... Cholangiocarcin... | A166 | 18 Years - | Klus Pharma Inc. | |
| A Study of Safety and Efficacy of KFA115 Alone and in Combination With Pembrolizumab in Patients With Select Advanced Cancers | NCT05544929 | Carcinoma, Non-... Cutaneous Melan... Carcinoma, Rena... Carcinoma, Ovar... Nasopharyngeal ... Carcinoma, Thym... Anal Cancer Mesothelioma Esophagogastric... High Microsatel... Squamous Cell C... Triple Negative... | KFA115 pembrolizumab | 18 Years - | Novartis | |
| VivaNet Study. A Multicenter Study of Confocal Reflectance Microscopy in Telemedicine | NCT01385943 | Skin Cancer Skin Lesions | 5 Years - | Lucid | ||
| Axitinib + Ipilimumab in Advanced Melanoma | NCT04996823 | Melanoma | Ipilimumab Axitinib | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Topical Sirolimus in Chemoprevention of Facial Squamous Cell Carcinomas in Solid Organ Transplant Recipients (SiroSkin) | NCT05860881 | Solid Organ Tra... Skin Cancer | Sirolimus Topic... Placebo | 18 Years - | Melanoma and Skin Cancer Trials Limited | |
| The Vitamin D Dose-Response Relationship | NCT01074541 | Vitamin D Statu... | UVB UVB UVB UVB | 18 Years - 65 Years | Bispebjerg Hospital | |
| Using Physical Tracking to Predict Sunburn | NCT04977700 | Prevention | Intervention Gr... | 18 Years - | Klein Buendel, Inc. | |
| A Mobile Text Messaging Intervention for Indoor Tanning Addiction | NCT04055272 | Indoor Tanning | Mobile text mes... | 18 Years - 30 Years | Georgetown University | |
| A Personal Cancer Vaccine (NEO-PV-01) w/ Nivolumab for Patients With Melanoma, Lung Cancer or Bladder Cancer | NCT02897765 | Urinary Bladder... Bladder Tumors Transitional Ce... Malignant Melan... Melanoma Skin Cancer Carcinoma, Non-... Lung Cancer | NEO-PV-01 Nivolumab Adjuvant | 18 Years - | BioNTech SE | |
| Study to Assess Safety and Immune Response of Stage IIB-IV Resected Melanoma After Treatment With MAGE-A3 ASCI | NCT01425749 | Melanoma | recMAGE-A3 + AS... | 18 Years - | University of Virginia | |
| Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Melanoma | NCT00040352 | Melanoma Dysplastic Nevu... | 4 Weeks - | National Institutes of Health Clinical Center (CC) | ||
| Itch and Pain Characteristics in Skin Carcinomas | NCT03290989 | Skin Carcinoma Skin Cancer Pruritus | 18 Years - | University Hospital, Brest | ||
| IL2 With Ipilimumab Followed by Nivolumab in Stage 3 or 4 Melanoma Patients | NCT04562129 | Melanoma Stage ... Melanoma Stage ... Inoperable Dise... | Interleukin-2 Ipilimumab Nivolumab | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Optical Imaging of Skin Cancers for Margin Delineation of Non-Melanoma Skin Cancers | NCT00432471 | Skin Cancer | Optical Imaging | 18 Years - | M.D. Anderson Cancer Center | |
| Applicability of a Cellular Resolution Full-field OCT Image System for Pigmented and Non-pigmented Skin Tumors | NCT05068310 | Skin Lesion Skin Cancer | Cellular resolu... Confocal micros... Optical coheren... Dermoscopy imag... | 18 Years - | Apollo Medical Optics, Ltd | |
| Symptom Burden in Patients With Cancer- and Treatment-Related Skin Problems | NCT01193036 | Skin Cancer | Part 1: Intervi... Part 2: Multipl... | 18 Years - | M.D. Anderson Cancer Center | |
| Multimodal Spectroscopy (MMS) for in Vivo Noninvasive Assessment of Skin | NCT02704039 | Skin Cancer | 18 Years - | University of Texas at Austin | ||
| ACCEPTABILITY AND WRITING FREQUENCY OF ADVANCED DIRECTIVES IN ONCO-DERMATOLOGY PATIENTS | NCT03822988 | Advance Directi... Oncology Skin Cancer Melanoma Skin Lymphoma Skin Squamous C... Metastatic Basa... | no intervention... | 18 Years - | Central Hospital, Nancy, France | |
| Comparative Retrospective Analysis of Skin Tumors of the Eyelids and Face in 2 Brussels University Hospitals Over 5 Years in Dermatology or Ophthalmology | NCT04886908 | Skin Cancer | Data extraction... | 18 Years - | Brugmann University Hospital | |
| Safety Study of CALAA-01 to Treat Solid Tumor Cancers | NCT00689065 | Cancer Solid Tumor | CALAA-01 | 18 Years - | Calando Pharmaceuticals | |
| Analysis of Skin Lesions for Melanoma Presence by Volatile Spectroscopy Techniques | NCT02393001 | Melanoma | Dermatology pat... Dermatology pat... Dermatology pat... Dermatology pat... | 18 Years - | University of Florida | |
| Naltrexone and Propranolol Combined With Immunotherapy | NCT05968690 | Advanced Melano... | Propranolol Naltrexone | 18 Years - | Rutgers, The State University of New Jersey | |
| Pilot Trial of Supplemental Vitamin A and Nicotinamide | NCT05702398 | Skin Cancer Kidney Transpla... | Vitamin A Nicotinamide Other: Placebo | 18 Years - | Rhode Island Hospital | |
| Evaluation of Pigmented Skin Lesions With MelaFind(R) System | NCT00434057 | Melanoma | MelaFind(R) | - | MELA Sciences, Inc. | |
| Phase 1 Study of CK-301 (Cosibelimab) as a Single Agent in Subjects With Advanced Cancers | NCT03212404 | Lung Neoplasms Carcinoma, Non-... Carcinoma, Smal... Malignant Mesot... Head and Neck C... Melanoma Merkel Cell Car... Renal Cell Carc... Urothelial Carc... Classical Hodgk... Cutaneous Squam... Non Hodgkin Lym... Endometrial Can... | CK-301 (cosibel... | 18 Years - | Checkpoint Therapeutics, Inc. | |
| IL2 With Ipilimumab Followed by Nivolumab in Stage 3 or 4 Melanoma Patients | NCT04562129 | Melanoma Stage ... Melanoma Stage ... Inoperable Dise... | Interleukin-2 Ipilimumab Nivolumab | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Skin Cancer in Swiss Transplant Cohort Study | NCT02361229 | Skin Cancer | 1 Hour - | University of Zurich | ||
| PLANNED VISUAL EDUCATION ABOUT SKIN CANCER | NCT05788939 | Skin Neoplasm | Planned Visual ... | 18 Years - 24 Years | Celal Bayar University | |
| Exercise to Boost Response to Checkpoint Blockade Immunotherapy | NCT05358938 | Cutaneous Melan... Cutaneous Squam... Merkel Cell Car... | Exercise Checkpoint Bloc... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
